Moderna
MRNA
#1663
Rank
C$13.49 B
Marketcap
$34.90
Share price
2.33%
Change (1 day)
-75.79%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -$12.31

According to Moderna 's latest financial reports the company's current EPS (TTM) is -$12.61. In 2022 the company made an earnings per share (EPS) of $29.15 a decrease over its 2021 EPS that were of $41.79.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.31-142.23%
2022$29.15-30.25%
2021$41.79-1660.82%
2020-$2.6825.16%
2019-$2.1437.04%
2018-$1.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.33-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.51-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.18-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.67-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.16-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.35-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.44-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA